SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 145 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $226,368 | -10.6% | 9,791 | +1.4% | 0.00% | 0.0% |
| Q2 2023 | $253,259 | -1.0% | 9,659 | -2.8% | 0.00% | 0.0% |
| Q1 2023 | $255,881 | +21.3% | 9,941 | +34.6% | 0.00% | 0.0% |
| Q3 2022 | $211,000 | -29.9% | 7,385 | +38.7% | 0.00% | 0.0% |
| Q1 2022 | $301,000 | -8.2% | 5,325 | +0.7% | 0.00% | 0.0% |
| Q4 2021 | $328,000 | -3.2% | 5,289 | -1.1% | 0.00% | -33.3% |
| Q3 2021 | $339,000 | -22.8% | 5,346 | +0.4% | 0.00% | -25.0% |
| Q2 2021 | $439,000 | +5.0% | 5,325 | -6.2% | 0.00% | 0.0% |
| Q1 2021 | $418,000 | +3.7% | 5,678 | +2.2% | 0.00% | 0.0% |
| Q4 2020 | $403,000 | – | 5,558 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 7,281,307 | $347,100,000 | 32.35% |
| BVF INC/IL | 2,053,991 | $97,914,000 | 5.33% |
| Samsara BioCapital, LLC | 398,017 | $18,973,000 | 5.29% |
| Orbimed Advisors | 7,406,307 | $353,059,000 | 4.44% |
| Consonance Capital Management LP | 602,732 | $28,732,000 | 3.50% |
| Boxer Capital, LLC | 2,075,905 | $98,958,000 | 3.42% |
| Perceptive Advisors | 3,481,148 | $165,946,000 | 2.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,234,262 | $58,837,000 | 1.43% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 974,915 | $46,474,000 | 0.95% |
| HighVista Strategies LLC | 11,477 | $547,000 | 0.40% |